Pathophysiological Mechanisms in Osteoarthritis Lead to Novel Therapeutic Strategies

Cells Tissues Organs - Tập 174 Số 1-2 - Trang 34-48 - 2003
Charles J. Malemud1, Najmul Islam, Tariq M. Haqqi
1Department of Medicine, Case Western Reserve University School of Medicine, and Research Institute of University Hospitals of Cleveland, Ohio 44106-5076, USA. [email protected]

Tóm tắt

Osteoarthritis (OA) is a debilitating, progressive disease of diarthrodial joints associated with aging. At the molecular level, OA is characterized by an imbalance between anabolic (i.e. extracellular matrix biosynthesis) and catabolic (i.e. extracellular matrix degradation) pathways in which articular cartilage is the principal site of tissue injury responses. The pathophysiology of OA also involves the synovium in that ‘nonclassical’ inflammatory synovial processes contribute to OA progression. Chondrocytes are critical to the OA process in that the progression of OA can be judged by the vitality of chondrocytes and their ability to resist apoptosis. Growth factors exemplified by insulin-like growth factor-1, its binding proteins and transforming growth factor-β contribute to anabolic pathways including compensatory biosynthesis of extracellular matrix proteins. Catabolic pathways are altered by cytokine genes such as interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) which are upregulated in OA. In addition, IL-1 and TNF-α downregulate extracellular matrix protein biosynthesis while concomitantly upregulating matrix metalloproteinase (MMP) gene expression. When MMPs are activated, cartilage extracellular matrix degradation ensues apparently because levels of endogenous cartilage MMP inhibitors cannot regulate MMP activity. Therapeutic strategies designed to modulate the imbalance between anabolic and catabolic pathways in OA may include neutralizing cytokine activity or MMP gene expression or inhibiting signaling pathways which result in apoptosis dependent on mature caspase activity or mitogen-activated protein kinase (MAPK) activity. MAPK activity appears critical for regulating chondrocyte and synoviocyte apoptosis and MMP genes.

Từ khóa


Tài liệu tham khảo

10.1074/jbc.274.33.23443

10.1002/(SICI)1097-0185(199804)250:4<418::AID-AR4>3.3.CO;2-B

10.1126/science.281.5381.1322

10.1002/art.10554

10.1006/geno.1994.1016

10.1126/science.281.5381.1305

10.1053/joca.2001.0488

10.1038/32588

10.1074/jbc.272.24.15496

10.1016/S0092-8674(00)81265-9

10.1053/sarh.2001.23701

10.1038/377646a0

10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.3.CO;2-C

10.1074/jbc.M204104200

10.1126/science.278.5345.1966

10.1016/0092-8674(95)90071-3

10.1038/sj.cdd.4400729

10.1084/jem.191.12.2031

10.1074/jbc.274.23.16604

10.1053/joca.2001.0468

10.1172/JCI200215197

10.1084/jem.190.12.1725

10.1126/science.281.5381.1317

10.1002/(SICI)1097-4644(19990915)74:4<576::AID-JCB7>3.3.CO;2-E

10.1002/1097-0029(20000801)50:3<236::AID-JEMT7>3.0.CO;2-E

10.1146/annurev.physiol.54.1.135

10.1074/jbc.M107443200

10.1038/370555a0

10.1126/science.281.5381.1309

10.1023/A:1016089607548

10.1172/JCI200112466

10.1002/art.10104

10.1073/pnas.96.8.4524

10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0

10.1002/jcb.10138

10.1002/jcb.10317

10.1053/joca.2001.0465

10.1002/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P

10.1159/000047889

10.1006/cbir.2002.0918

10.1002/jcb.1097

10.1074/jbc.M107231200

10.1126/science.275.5303.1132

10.1006/bbrc.2001.5177

10.1016/S0736-0266(01)00023-7

10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S

10.1016/S0014-5793(00)01854-8

10.1016/S0092-8674(00)81871-1

10.1016/S0092-8674(00)80434-1

10.1006/excr.2000.5036

10.1056/NEJM200011303432202

10.1002/1529-0131(200007)43:7<1552::AID-ANR20>3.3.CO;2-N

10.1074/jbc.M200431200

10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4

10.1006/bbrc.1995.1003

10.1016/S0092-8674(00)81266-0

10.1038/35065201

10.1038/18465

10.1159/000047890

10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F

10.1038/38525

10.1159/000047888

10.1083/jcb.124.1.1

10.1016/S0092-8674(00)80515-2

10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3

10.1073/pnas.96.20.10964

10.1074/jbc.M009737200

10.1074/jbc.M010859200

10.1002/art.10443

10.1016/S0736-0266(02)00089-X

10.1038/sj.cdd.4400889

10.1074/jbc.275.15.11327

10.1084/jem.186.1.25

10.1126/science.281.5381.1312

10.1126/science.284.5420.1664

10.1067/mlc.2001.115938

10.1172/JCI200113508

10.1053/joca.2002.0521

10.1053/joca.1998.0109

10.1053/joca.1999.0292

10.1083/jcb.139.5.1281

10.1038/89769

10.1126/science.275.5303.1129

10.1046/j.0300-9475.2001.01033.x

10.1038/369321a0

10.1002/(SICI)1097-4644(19960201)60:2<211::AID-JCB5>3.0.CO;2-#